Acorda Therapeutics

Acorda filed for bankruptcy, and Merz is eyeing its assets
Pharmaphorum
Tue, 04/2/24 - 11:29 am
Acorda Therapeutics
Merz
bankruptcy
Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda
Fierce Pharma
Thu, 01/11/24 - 08:45 pm
Biogen
Fampyra
MS
multiple sclerosis
Acorda Therapeutics
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Acorda loses its last shot at protecting its cash cow franchise drug. It’s up to Inbrija now
Endpoints
Mon, 10/7/19 - 11:08 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Supreme Court
Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave
Xconomy
Fri, 03/8/19 - 10:04 am
Acorda Therapeutics
Parkinson's Disease
Andrew Hindman
Inbrija
Battered Acorda pulls off delayed Parkinson’s approval for Inbrija
Fierce Pharma
Wed, 12/26/18 - 04:47 pm
Acorda Therapeutics
parkinson's
Inbrija
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
FDA Pushes Back PDUFA Date of Acorda's Parkinson’s Drug
CP Wire
Thu, 09/13/18 - 09:40 am
Acorda Therapeutics
Inbrija
Parkinson's Disease
FDA
FDA Pushes Back PDUFA Date of Acorda's Parkinson’s Drug
Thu, 09/13/18 - 09:26 am
Acorda Therapeutics
Inbrija
Parkinson's Disease
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Biopharma Dive
Mon, 09/10/18 - 11:54 pm
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
patents
Acorda looks to Inbrija launch as Ampyra court battle continues
Biopharma Dive
Fri, 08/3/18 - 10:59 pm
Acorda Therapeutics
Inbrija
AMPYRA
Here's Why Acorda Therapeutics Rose as Much as 30.3% Today
Motley Fool
Fri, 06/8/18 - 11:36 pm
Acorda Therapeutics
AMPYRA
patents
CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect
Fierce Pharma
Wed, 06/6/18 - 11:33 am
drug reps
layoffs
Acorda Therapeutics
AMPYRA
generics
This biotech CEO’s lousy job performance cost shareholders money, so his board docked his pay
Stat
Mon, 04/30/18 - 09:41 am
Acorda Therapeutics
Ron Cohen
executive pay
[forum discussion]Why is Scopia Capital investing in Acorda Therapeutics?
Cafepharma Message Boards
Mon, 03/12/18 - 09:44 am
Acorda Therapeutics
Scopia Capital
Inbrija
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
AbbVie
Allergan
Roche
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Acorda posts Q4 revenue beat, but misses EPS estimates
Drug Delivery Business News
Thu, 02/15/18 - 11:39 pm
Acorda Therapeutics
earnings
Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows — report
Endpoints
Fri, 01/19/18 - 11:15 am
Biogen
UCB Pharma
Acorda Therapeutics
M&A
Acorda writes off $363M drug, axing PhIII Parkinson’s drug in the wake of 5 patient deaths
Endpoints
Mon, 11/20/17 - 09:31 am
Acorda Therapeutics
Parkinson's Disease
tozadenant
clinical trials
Acorda faces new trouble with trial halt, safety problems
BioPharma Dive
Wed, 11/15/17 - 08:47 pm
Acorda Therapeutics
clinical trials
tozadenant
Parkinson's Disease

Pages